Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study.

R, Francavilla; E, Lionetti; SP, Castellaneta; AM, Magistà; G, Maurogiovanni; N, Bucci; Canio A, De; F, Indrio; L, Cavallo; E, Ierardi; VL, Miniello

doi:10.1111/j.1523-5378.2008.00593.x

Public

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study.

Shared by NobleBlocks on Apr 1, 2008 • 12:00 AM UTC

Authors:

Francavilla R

Lionetti E

Castellaneta SP

Abstract

Background Several studies report an inhibitory effect of probiotics on Helicobacter pylori.Aim To test whether Lactobacillus reuteri ATCC 55730 reduces H. pylori intragastric load in vivo, decreases dyspeptic symptoms, and affects eradication rates after conventional treatment.Materials and methods...

Discussions